Cue Biopharma, Inc. (CUE) Debt Components
- 2025-03-31: Short-term DebtUSD $100.00K; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2024-12-31: Short-term DebtUSD $37.00K; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m).
- 2024-09-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $4.00M; Long-term Debt, Excluding Current MaturitiesUSD $1.33M; Long-term DebtUSD $1.00M.
- 2024-06-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $4.00M; Long-term Debt, Excluding Current MaturitiesUSD $2.29M; Long-term DebtUSD $2.00M.
Cue Biopharma, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $100.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $37.00K | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $4.00M | $1.33M | $1.00M | $1.00M | $4.00M | $5.00M | $-37.00K | (m) | (m) |
| 2024-06-30 | (m) | $4.00M | $2.29M | $2.00M | $2.00M | $4.00M | $6.00M | $-37.00K | (m) | (m) |
| 2024-03-31 | $37.00K | $4.00M | $3.24M | $3.00M | $3.00M | $4.00M | $7.00M | $-37.00K | (m) | (m) |
| 2023-12-31 | (m) | (m) | $4.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $37.00K | $4.00M | (m) | $4.00M | $4.00M | $4.00M | $8.00M | $-37.00K | (m) | (m) |
| 2023-09-30 | (m) | $4.00M | $5.16M | $5.00M | $1.00M | $4.00M | $9.00M | $-46.00K | $4.00M | (m) |
| 2023-06-30 | (m) | $4.00M | $6.12M | $6.00M | $2.00M | $4.00M | $10.00M | $-55.00K | $4.00M | (m) |
| 2023-03-31 | (m) | $3.00M | $7.08M | $7.00M | $2.00M | $4.00M | $10.00M | $-65.00K | $4.00M | (m) |
| 2022-12-31 | (m) | (m) | $8.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $73.97K | $2.00M | (m) | $8.00M | $2.00M | $4.00M | $10.00M | $-74.00K | $4.00M | (m) |
| 2022-09-30 | $37.00K | $1.00M | $8.99M | $9.00M | $2.00M | $4.00M | $10.00M | $-83.00K | $4.00M | $0.00 |
| 2022-06-30 | (m) | (m) | $9.91M | $9.91M | $2.00M | $4.00M | $10.00M | $-130.00K | $4.00M | $0.00 |
| 2022-03-31 | (m) | (m) | $9.86M | $9.86M | $4.00M | $4.00M | $10.00M | $139.00K | (m) | $2.00M |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |